Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

...11121314151617181920...
CompanyDrug NameStatusIndication Group
Epeius Biotechnologies Rexin-GTM in Phase IAntineoplastic & immunomodulating agents
Celgene Revlimid accomplished Phase IIIAntineoplastic & immunomodulating agents
Celgene Revlimid accomplished Phase IIAntineoplastic & immunomodulating agents
Celgene Revlimid accomplished Phase IIBlood & blood forming organs
Pfizer Revatio Approved in USA and EUCardiovascular system
Bausch & Lomb Retisert Approved in USASensory organs
Alcon Laboratories Retaane Approved in Australia and USASensory organs
AVI BioPharma Resten–MP in Phase IICardiovascular system
Teva Pharmaceutical Respicort in Phase IIRespiratory system
Zivena Resmycin in Phase IIAntineoplastic & immunomodulating agents
GlaxoSmithKline ReQuip CR in Phase IIINervous system
SkyePharma Requip Approved in FranceNervous system
GlaxoSmithKline ReQuip in Phase INervous system
Human Genome Sciences Repifermin accomplished Phase IIAlimentary tract & metabolism
Johnson & Johnson REoPro discontinuedCardiovascular system
Oncolytics Biotech Reolysin and radiotherapy in Phase IIAntineoplastic & immunomodulating agents
Oncolytics Biotech Reolysin accomplished Phase IAntineoplastic & immunomodulating agents
Oncolytics Biotech Reolysin in Phase IIAntineoplastic & immunomodulating agents
Oncolytics Biotech Reolysin in Phase IIAntineoplastic & immunomodulating agents
Oncolytics Biotech Reolysin in Phase IIAntineoplastic & immunomodulating agents
...11121314151617181920...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.